Perineural Therapy Market Analysis

Biomaterials (Nerve Conduits, Nerve Wraps)

The perineural therapy market is segmented and analyzed for demand and supply by biomaterials into nerve conduits and nerve wraps, out of which, the nerve conduits segment is set to witness noteworthy growth over the forecast period. The growth of the segment can be ascribed to rising cases of nerve damage on account of multiple causes, such as sports injuries and changing lifestyles. For instance, it has been estimated that over 100 types of nerve damage exist that require significant medical attention.

End-user (Clinics, Hospitals, Ambulatory Surgical Centers)

The perineural therapy market is segmented and analyzed for the demand & supply by end users to Hospitals and clinics, ambulatory surgical centers, and others. Among these, it is estimated that hospitals and clinics have the chance to have the largest market share in the forecast year. People suffering from more nerve disorders and geriatric populations having nerve issues are the actual growth drivers of this segment. The incorporation of new nerve regeneration and nerve repair technologies and investment by the government in the research and development of this technology is also expected to drive the growth of this segment.

Our in-depth analysis of the global market includes the following segments:

By Internal Neurostimulation Devices	Spinal Cord Vagus Nerve Deep Brain Gastric Electrical Sacral Nerve
By End User	Hospitals and Clinics Ambulatory Surgical Centers Others
By Biomedicals	Nerve Conduits Nerve Wraps
By External Neurostimulation Devices	RES TMS TENS

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of perineural therapy is estimated at USD 394.18 Million.

The perineural therapy market size was over USD 346.2 Million in 2023 and is set to cross USD 2.22 Billion by the end of 2036, growing at more than 15.4% CAGR during the forecast period i.e., between 2024-2036. The higher prevalence of different sorts of neural disorders and the increment in approval of more enhanced products to repair and regenerate nerves are the major factors driving the market growth.

North America is projected to account for majority industry share by 2036, on the back of a higher prevalence of sports injuries.

Boston Scientific Corporation, tVNS Technologies GmbH, Abbott Laboratories, NeuroSigma, Inc., Axogen Corporation, BioWave Limited, Baxter Healthcare Corporation, LivaNova, PLC, Integra LifeSciences Corporation, Soterix Medical, Inc.

Perineural Therapy Market Analysis